Formulation Variables Influencing the Development of Ketoconazole Gastroretentive Drug Delivery System

Moamin Fattah Al Hablawi; Iman Sabah Jaffar

doi:10.54133/ajms.v7i1(Special).867

Authors

Moamin Fattah Al Hablawi Department of Pharmaceutics, College of Pharmacy, Mustansiriyah University, Baghdad, Iraq. https://orcid.org/0000-0002-2652-0229
Iman Sabah Jaffar Department of Pharmaceutics, College of Pharmacy, Mustansiriyah University, Baghdad

DOI:

https://doi.org/10.54133/ajms.v7i1(Special).867

Keywords:

Drug delivery, Gasteroretaintive, Mucoadhesive, Residence time

Abstract

Background: Ketoconazole (KZ) is categorized as class II according to the Biopharmaceutics Classification System (BSC) classification, which shows a strong pH-dependent solubility where its solubility is enhanced under an acidic medium (pH below 3). This strong pH dependence results in unpredictable absorption and a wide range of bioavailabilities. Objective: To prolong the gastric residence time of KZ’s tablet to enhance KZ’s solubility and hence its bioavailability for better therapeutic activity. Methods: To prepare mucoadhesive tablets, we use both direct and wet granulation methods. We employed various evaluation tests to assess the prepared tablets. These tests encompass a range of assessments, including weight variation, hardness, thickness, friability, disintegration test, swelling study, mucoadhesive strength study, and in vitro drug release studies. Results: The study found that polymer viscosity, as well as polymer concentration, have a significant effect on mucoadhesive strength and drug release, whereas diluent type has a non-significant influence on drug release. We selected Formula 7, which employs xanthan gum as a mucoadhesive polymer in a 1:1 drug polymer ratio, as the optimum formula because it provides an accepted physico-mechanical property and releases 87% of the drug over 8 hours. Conclusions: Gastric mucoadhesive tablets may be an effective method of delivering active ingredients, as they provide a favorable environment that enhances their dissolution by extending their duration in the stomach, thereby increasing their bioavailability.

Downloads

Download data is not yet available.

References

Dan N, Samanta K, Almoazen H. An update on pharmaceutical strategies for oral delivery of therapeutic peptides and proteins in adults and pediatrics. Children (Basel). 2020;7(12). doi: 10.3390/children7120307. DOI: https://doi.org/10.3390/children7120307

Sabar MH, Jaafar IS, Mohamed MBM. In situ gel as a platform for ketoconazole slow-release dosage form. Int J App Pharm. 2018;10(5):76-80. doi: 10.22159/ijap.2018v10i5.27849. DOI: https://doi.org/10.22159/ijap.2018v10i5.27849

Vinchurkar K, Sainy J, Khan MA, Mane S, Mishra DK, Dixit P. Features and facts of a gastroretentive drug delivery system- A review. Turk J Pharm Sci. 2022;19(4):476-487. doi: 10.4274/tjps.galenos.2021.44959. DOI: https://doi.org/10.4274/tjps.galenos.2021.44959

Kumar R, Islam T, Nurunnabi M. Mucoadhesive carriers for oral drug delivery. J Control Release. 2022;351:504-559. doi 10.1016/j.jconrel.2022.09.024. DOI: https://doi.org/10.1016/j.jconrel.2022.09.024

Tripathi J, Thapa P, Maharjan R, Jeong SH. Current state and future perspectives on gastroretentive drug delivery systems. Pharmaceutics. 2019;11(4). doi: 10.3390/pharmaceutics11040193. DOI: https://doi.org/10.3390/pharmaceutics11040193

Zahir-Jouzdani F, Wolf JD, Atyabi F, Bernkop-Schnürch A. In situ gelling and mucoadhesive polymers: why do they need each other? Expert Opin Drug Deliv. 2018;15(10):1007-1019. doi: 10.1080/17425247.2018.1517741. DOI: https://doi.org/10.1080/17425247.2018.1517741

Bernkop-Schnürch A. Mucoadhesive polymers: Basics, strategies, and trends. Concise Encyclopedia of Biomedical Polymers and Polymeric Biomaterials: CRC Press; 2017. p. 941-960. doi: 10.1081/E-EBPPC. DOI: https://doi.org/10.1081/E-EBPPC-120052253

Dudhipala N, Ay AA. Amelioration of ketoconazole in lipid nanoparticles for enhanced antifungal activity and bioavailability through oral administration for management of fungal infections. Chem Phys Lipids. 2020;232:104953. doi: 10.1016/j.chemphyslip.2020.104953. DOI: https://doi.org/10.1016/j.chemphyslip.2020.104953

Kara DD, Bangera PD, Mehta CH, Tanvi K, Rathnanand M. In silico screening as a tool to prepare drug-drug cocrystals of ibrutinib-ketoconazole: A strategy to enhance their solubility profiles and oral bioavailability. AAPS PharmSciTech. 2023;24(6):164. doi: 10.1208/s12249-023-02621-9. DOI: https://doi.org/10.1208/s12249-023-02621-9

Fung M, Be Rziņš KR, Suryanarayanan R. Physical stability and dissolution behavior of ketoconazole-organic acid coamorphous systems. Mol Pharm. 2018;15(5):1862-869. doi: 10.1021/acs.molpharmaceut.8b00035. DOI: https://doi.org/10.1021/acs.molpharmaceut.8b00035

Wishart DS, Feunang YD, Guo AC, Lo EJ, Marcu A, Grant JR, et al. DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res. 2017 Nov 8. doi: 10.1093/nar/gkx1037. [cited 15-6-2024]. DOI: https://doi.org/10.1093/nar/gkx1037

Kataoka M, Fukahori M, Ikemura A, Kubota A, Higashino H, Sakuma S, et al. Effects of gastric pH on oral drug absorption: In vitro assessment using a dissolution/permeation system reflecting the gastric dissolution process. Eur J Pharm Biopharm. 2016;101:103-111. doi: 10.1016/j.ejpb.2016.02.002. DOI: https://doi.org/10.1016/j.ejpb.2016.02.002

Jin H, Ngo HV, Park C, Lee BJ. Mucoadhesive buccal tablet of leuprolide and its fatty acid conjugate: Design, in vitro evaluation and formulation strategies. Int J Pharm. 2023;639:122963. doi: 10.1016/j.ijpharm.2023.122963. DOI: https://doi.org/10.1016/j.ijpharm.2023.122963

Macho O, Gabrišová Ľ, Guštafík A, Jezso K, Juriga M, Kabát J, et al. The influence of wet granulation parameters on the compaction behavior and tablet strength of a hydralazine powder mixture. Pharmaceutics. 2023;15(8). doi: 10.3390/pharmaceutics15082148. DOI: https://doi.org/10.3390/pharmaceutics15082148

Patil S, Talele GS. Gastroretentive mucoadhesive tablet of lafutidine for controlled release and enhanced bioavailability. Drug Deliv. 2015;22(3):312-319. doi: 10.3109/10717544.2013.877099. DOI: https://doi.org/10.3109/10717544.2013.877099

Chakraborty M, Ridgway C, Bawuah P, Markl D, Gane PAC, Ketolainen J, et al.Optics-based compressibility parameter for pharmaceutical tablets obtained with the aid of the terahertz refractive index. Int J Pharm. 2017;525(1):85-91. doi: 10.1016/j.ijpharm.2017.03.093. DOI: https://doi.org/10.1016/j.ijpharm.2017.03.093

Mohylyuk V, Bandere D. High-speed tableting of high drug-loaded tablets prepared from fluid-bed granulated isoniazid. Pharmaceutics. 2023;15(4). doi: 10.3390/pharmaceutics15041236. DOI: https://doi.org/10.3390/pharmaceutics15041236

Razzaq S, Hanif S, Syed MA, Iqbal J, Hassan SS, Raza SA, et al. Development and evaluation of mucoadhesive buccal tablet containing metronidazole for the treatment of periodontitis and gingivitis. Pak J Pharm Sci. 2018;31(5):1903-1910. PMID: 30150187.

Javed QUA, Syed MA, Arshad R, Rahdar A, Irfan M, Raza SA, et al. Evaluation and optimization of prolonged-release mucoadhesive tablets of dexamethasone for wound healing: In vitro-in vivo profiling in healthy volunteers. Pharmaceutics. 2022;14(4). doi: 10.3390/pharmaceutics14040807. DOI: https://doi.org/10.3390/pharmaceutics14040807

Hussain A, Syed MA, Abbas N, Hanif S, Arshad MS, Bukhari NI, et al. Development of an ANN optimized mucoadhesive buccal tablet containing flurbiprofen and lidocaine for dental pain. Acta Pharm. 2016;66(2):245-256. doi: 10.1515/acph-2016-0020. DOI: https://doi.org/10.1515/acph-2016-0020

Sharma OP, Shah MV, Parikh DC, Mehta TA.Formulation optimization of gastroretentive drug delivery system for allopurinol using experimental design. Expert Opin Drug Deliv. 2015;12(4):513-524. doi: 10.1517/17425247.2014.944861. DOI: https://doi.org/10.1517/17425247.2014.944861

Li A, Khan IN, Khan IU, Yousaf AM, Shahzad Y. Gellan gum-based bilayer mucoadhesive films loaded with moxifloxacin hydrochloride and clove oil for possible treatment of periodontitis. Drug Des Devel Ther. 2021;15:3937-3952. doi: 10.2147/dddt.S328722. DOI: https://doi.org/10.2147/DDDT.S328722

Mohsin BM, Sabah IJ, Hamad MS, Hazem MJ, Furqan MA, Doaa ZA. Oily in situ gels as an alternative floating platform for ketoconazole release. Int J Res Pharm Sci. 2020;11(2):2638-2649. doi: doi.org/10.26452/ijrps.v11i2.2278. DOI: https://doi.org/10.26452/ijrps.v11i2.2278

Zeeshan F, Lin PY, Sheshala R. Application of similarity factor (f 2) and time required to drug release (t%) indicators for dissolution profiles comparison of paracetamol tablets. Indian J Pharm Edu Res. 2020;54(3). doi: 10.5530/ijper.54.3.114. DOI: https://doi.org/10.5530/ijper.54.3.114

Jiang WZ, Cai Y, Li HY. Chitosan-based spray-dried mucoadhesive microspheres for sustained oromucosal drug delivery. Powder Technol. 2017;312:124-132. doi: 10.1016/j.powtec.2017.02.021. DOI: https://doi.org/10.1016/j.powtec.2017.02.021

The United State Pharmacopeia (USP) 30, NF28, 2010, USA: The United State Pharmacopia Convention Inc. 2010.

Grassiri B, Zambito Y, Bernkop-Schnürch A. Strategies to prolong the residence time of drug delivery systems on ocular surface. Adv Colloid Interface Sci. 2021;288:102342. doi: 10.1016/j.cis.2020.102342. DOI: https://doi.org/10.1016/j.cis.2020.102342

Agarwal S, Murthy RS. Effect of different polymer concentration on drug release rate and physicochemical properties of mucoadhesive gastroretentive tablets. Indian J Pharm Sci. 2015;77(6):705-714. doi: 10.4103/0250-474x.174993. DOI: https://doi.org/10.4103/0250-474X.174993

Ammanage A, Rodriques P, Kempwade A, Hiremath R. Formulation and evaluation of buccal films of piroxicam co-crystals. Future J Pharm Sci. 2020;6(1):16. doi: 10.1186/s43094-020-00033-1. DOI: https://doi.org/10.1186/s43094-020-00033-1

McArdle R, Hamill R. Utilisation of hydrocolloids in processed meat systems. In: Kerry JP, Kerry JF, (Eds.), Processed Meats: Woodhead Publishing; 2011. p. 243-69. doi: 10.1533/9780857092946.2.243. DOI: https://doi.org/10.1533/9780857092946.2.243

Argin S, Kofinas P, Lo YM. The cell release kinetics and the swelling behavior of physically crosslinked xanthan–chitosan hydrogels in simulated gastrointestinal conditions. Food Hydrocoll. 2014;40:138-144. doi: 10.1016/j.foodhyd.2014.02.018. DOI: https://doi.org/10.1016/j.foodhyd.2014.02.018

Yu T, Andrews GP, Jones DS. Mucoadhesion and characterization of mucoadhesive properties. In: das Neves J, Sarmento B, (Eds.), Mucosal Delivery of Biopharmaceuticals: Biology, Challenges and Strategies. Boston, MA: Springer US; 2014. p. 35-58. doi: 10.1007/978-1-4614-9524-6_2. DOI: https://doi.org/10.1007/978-1-4614-9524-6_2

Saurí J, Zachariah M, Macovez R, Tamarit JL, Millán D, Suñé-Pou M, et al. Formulation and characterization of mucoadhesive controlled release matrix tablets of captopril. J Drug Deliv Sci Technol. 2017;42:215-226. doi: doi.org/10.1016/j.jddst.2017.03.009. DOI: https://doi.org/10.1016/j.jddst.2017.03.009

Bayer IS. Recent advances in mucoadhesive interface materials, mucoadhesion characterization, and technologies. Adv Mater Interfaces. 2022;9(18):2200211 doi: doi.org/10.1002/admi.202200211. DOI: https://doi.org/10.1002/admi.202200211

Kumar BP, Kavitha P, Devi KJ. Formulation design and evaluation of mucoadhesive buccal tablets of nitroglycerin. Int J Pharmacy Pharm Sci. 2014;6(7):251-259.

Boddupalli BM, Mohammed ZN, Nath RA, Banji D. Mucoadhesive drug delivery system: An overview. J Adv Pharm Technol Res. 2010;1(4):381-387. doi: 10.4103/0110-5558.76436. DOI: https://doi.org/10.4103/0110-5558.76436

Dalvadi H, Patel J, Rajput G, Muruganantham V, Jayakar B. Development and characterization of controlled release mucoadhesive tablets of captopril. Ars Pharmaceutica. 2011;52(2):31-37.

Jaipal A, Pandey MM, Charde SY, Raut PP, Prasanth KV, Prasad RG. Effect of HPMC and mannitol on drug release and bioadhesion behavior of buccal discs of buspirone hydrochloride: In-vitro and in-vivo pharmacokinetic studies. Saudi Pharm J. 2015;23(3):315-326. doi: 10.1016/j.jsps.2014.11.012. DOI: https://doi.org/10.1016/j.jsps.2014.11.012

Newton AM, Lakshmanan P. Effect of HPMC - E15 LV premium polymer on release profile and compression characteristics of chitosan/pectin colon targeted mesalamine matrix tablets and in vitro study on effect of pH impact on the drug release profile. Recent Pat Drug Deliv Formul. 2014;8(1):46-62. doi: 10.2174/1872211308666140225143926. DOI: https://doi.org/10.2174/1872211308666140225143926

Toews P, Bates J. Influence of drug and polymer molecular weight on release kinetics from HEMA and HPMA hydrogels. Sci Rep. 2023;13(1):16685. doi: 10.1038/s41598-023-42923-3. DOI: https://doi.org/10.1038/s41598-023-42923-3

Dadou SM, Antonijevic MD, Chowdhry BZ, Badwan AA, (Eds.), An overview of chitosan-xanthan gum matrices as controlled release drug carriers, IntechOpen. 2018. doi: 10.5772/intechopen.76038. DOI: https://doi.org/10.5772/intechopen.76038

Sultana A, Aghajanzadeh S, Thibault B, Ratti C, Khalloufi S. Exploring conventional and emerging dehydration technologies for slurry/liquid food matrices and their impact on porosity of powders: A comprehensive review. Comprehen Rev Food Sci Food Safety. 2024;23(3):e13347. doi: doi.org/10.1111/1541-4337.13347. DOI: https://doi.org/10.1111/1541-4337.13347

Ma'ali A, Naseef H, Qurt M, Abukhalil AD, Rabba AK, Sabri I. The preparation and evaluation of cyanocobalamin mucoadhesive sublingual tablets. Pharmaceuticals (Basel). 2023;16(10). doi: 10.3390/ph16101412. DOI: https://doi.org/10.3390/ph16101412

Rashmitha V, Rao YM, Pavani S. Formulation and evaluation of fenoverine tablets. Asian J Pharm Clin Res. 2021;175-180. doi: 10.22159/ajpcr.2021.v14i4.40999. DOI: https://doi.org/10.22159/ajpcr.2021.v14i4.40999

Ghosal K, Adak S, Agatemor C, Praveeen G, Kalarikkal N, Thomas S. Novel interpenetrating polymeric network based microbeads for delivery of poorly water soluble drug. J Polymer Res. 2020;27(4):98. doi: 10.1007/s10965-020-02077-6. DOI: https://doi.org/10.1007/s10965-020-02077-6